Challenging Case Review: Breast Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with breast cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers. This peer interaction is an integral part in enhancing clinical decision-making skills that can improve patient care.
Advances in the Management of Metastatic Breast Cancer
With expanding treatment options, clinicians should understand important criteria used in selecting optimal first-and subsequent-line therapies for individuals with metastatic breast cancer. For clinicians, staying up to date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with the toxicity profiles is important to optimize patient outcomes.
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Breast Cancer

The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast cancer in Black patients.

Diagnosis and Management of Breast Cancer: What does the Evidence Show, What are We Doing, And What’s on the Horizon?

The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast cancer in Black patients.

Recognizing Bias and Health Care Disparities in Black Patients

The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast and prostate cancer in Black patients.

Advances in the Management of Metastatic Breast Cancer with SABCS Updates
With expanding treatment options, clinicians are challenged to understand important criteria used in selecting optimal first- and subsequent-line therapies for individuals with metastatic breast cancer. Staying up-to-date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with their toxicity profiles is important to optimize patient outcomes.
Breast Cancer Survivorship: The Importance of a Healthy Lifestyle
Few survivors meet all health behavior recommendations, and clinicians often report a lack of expertise, time, and resources to address healthy lifestyles with cancer survivors. Education on this topic can help clinicians encourage and support survivors to maintain and enhance their wellness.
Multigene and Biomarker Testing in Breast Cancer: What is the Role?
Clinicians need to know what, when, and how to test and how to make subsequent informed, patient‐personalized treatment decisions. Accurate interpretation of results is critical; over-interpretation or misinterpretation will lead to treatment of patients with ineffective and expensive therapies, negatively impacting patient outcomes.
Locoregional Management of Non-Invasive and Invasive Non-Metastatic Breast Cancer with SABCS Updates
In order to define clinical situations that require appropriate locoregional therapies and use the right approach, clinicians need to stay up-to-date on the updates as well as the controversies.
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates
By staying up-to-date on new approaches and options for neoadjuvant /adjuvant systemic therapy, the clinicians will be able to provide appropriate care using a shared decision-making process with the patient, taking into account patient and disease characteristics including risk of recurrence, and weighing the potential benefits and risks of each option. In addition, it is important for clinicians to be aware of new supportive care interventions available to improve the quality of life of patients.

Pages

Subscribe to RSS - Breast Cancer